Pancreatic cancer, Secondary cancers
Open
Phase 2
This trial is looking at adding a new drug called ginisortamab to chemotherapy for pancreatic cancer that has spread to other parts of the body. Cancer that has spread is advanced or metastatic cancer.
It is for people who haven’t yet had treatment for advanced pancreatic cancer.
You pronounce ginisortamab as gin-ee-saw-ta-mab.
Cancer Research UK supports this trial.
Recruitment start: 23 April 2024
Recruitment end: 31 July 2026
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Cancer Research UK (Centre for Drug Development)
UCB Biopharma SRL
This is Cancer Research UK trial number CRUKD/24/002.
Last reviewed: 29 Apr 2025
CRUK internal database number: 19221
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
